NCT02727634

Brief Summary

The heart is essentially a hydraulic pump which ensures adequate delivery of blood through generating pressure and forward flow of blood. The energy delivered by the heart is uncommonly measured clinically, and todays gold standard involves placing a plastic catheter into the lung arteries. The investigators have developed an ultrasound based approach to calculate this energy without the need for catheters through the heart. This novel approach is called ultrapower. Ultrapower involves the instantaneous multiplication of the cardiac output and the arterial blood pressure. The study aims to use the ultrasound based approach to investigate Cardiac Power in the coronary artery bypass graft population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 17, 2016

Completed
18 days until next milestone

First Posted

Study publicly available on registry

April 4, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

March 27, 2019

Status Verified

March 1, 2019

Enrollment Period

6 months

First QC Date

March 17, 2016

Last Update Submit

March 26, 2019

Conditions

Keywords

HemodynamicsEchocardiography, Doppler, Pulsed

Outcome Measures

Primary Outcomes (3)

  • The hearts energy delivery per second measured in watts (Cardiac Power), using two established methods and the ultrapower method

    Measured both as ultrapower and cardiac power output, both measured in watts and method of measurement described in intervention section

    Immediately preoperatively

  • The hearts energy delivery per second measured in watts (Cardiac Power), using two established methods and the ultrapower method

    approximately 1 hour post operatively

  • The hearts energy delivery per second measured in watts (Cardiac Power), using two established methods and the ultrapower method

    1 day after operation

Study Arms (1)

Postoperative elective CABG patients

OTHER

Patients included for coronary artery bypass graft (CABG) surgery, secondary to ischaemic heart disease.

Other: Comparison cardiac power and cardiac power output at different time points in the perioperative period

Interventions

The intervention is a comparison between two methods of calculating the heart's energy delivery, cardiac power, measured in watts. A tertiary measurement is calculation of arterioventricular coupling. All patients will have cardiac power output calculated through the use of Doppler echocardiography. The echocardiography based cardiac output will be done through the velocity time integral of the left ventricular outflow tract (LVOT). This will be compared against total power as measured by our Ultrapower approach which involves instantaneous doppler measurement of cardiac output through LVOT multiplied with simultaneous radial artery pressure. This and ejection fraction (for calculation of ventriculoarterial coupling) will be recorded at rest in neutral position preoperatively, directly post operatively and the day after operation. Directly postoperatively the power measurements will also be repeated in Trendelenburg and anti Trendelenburg position.

Postoperative elective CABG patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • coronary artery bypass graft operation

You may not qualify if:

  • Lack of informed consent
  • Previous aortic valve replacement
  • Inadequate Doppler signal on transthoracic echocardiography

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of cardiothoracic surgery

Trondheim, Norway

Location

MeSH Terms

Conditions

Heart Diseases

Condition Hierarchy (Ancestors)

Cardiovascular Diseases

Study Officials

  • Idar Kirkeby-Garstad, md phd

    Norwegian University of Science and Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 17, 2016

First Posted

April 4, 2016

Study Start

June 1, 2016

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

March 27, 2019

Record last verified: 2019-03

Locations